Breakthrough Therapies: NTRK

Episode
98
Soundcloud
Share

In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.

Guest
Narjust Duma
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Robert C. Doebele
Robert C. Doebele
Co-Founder and Chief Scientific Officer, Rain Therapeutics

Other Podcast

Lung Cancer Considered Episode 107 International Medical Graduates with Dr. Marina Chiara Garassino & Dr. Suresh Ramalingam
Episode
107
Lung Cancer Considered: ASCO Highlights 2022 with Jack West & Catherine Shu
Episode
106
Lung Cancer Considered ADC Podcast with Drs. Ben Levy and Rebecca Heist
Episode
105